IO Biotech
Break Boundaries. Ignite Change.
IO Biotech was founded in 2015, is headquartered in Copenhagen, United States, lists 51–200 employees, and has $223.1M in recorded funding across 2 rounds.
- Headquarters
- Copenhagen
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- iobiotech.com
- Total Funding
- $223.1M
- Last Round
- $75.0M Venture RoundAug 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 21 investors for this company. The full record is or through the API.
About
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its proprietary T-win® platform. Founded in 2015 and headquartered in Copenhagen, Denmark—with US headquarters in New York—IO Biotech's T-win technology is designed to activate T cells to target both tumor cells and immune-suppressive cells in the tumor microenvironment simultaneously. IO Biotech's lead cancer vaccine candidate, Cylembio (formerly IO102-IO103), has advanced into clinical trials, with Phase 1/2 data published in Nature Communications demonstrating long-term clinical and immunological outcomes in first-line metastatic melanoma in combination with PD-1 blockade. The company's pipeline includes additional candidates targeting Arginase 1 (IO112) and TGF-β expressing cells (IO170). IO Biotech is a publicly traded company (Nasdaq: IOBT).
Summary
IO Biotech is a Biotech company based in Copenhagen, United States, founded in 2015. It lists 51–200 employees. It has raised $223.1M in total across 2 rounds, most recently a $75.0M Venture Round in Aug 2023. Investors include HBM Healthcare Investments, European Investment Bank and Vivo Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2024
Sign up to see all 3 events
Funding: Series B through Venture Round. Amounts, valuations, and investors where available.
Investors
HBM Healthcare Investments
2 rounds
European Investment Bank
1 round
Vivo Capital
2 rounds
Samsara BioCapital
2 rounds
PFM Health Sciences
2 rounds
Sunstone Life Science Ventures
2 rounds
Lundbeckfonden BioCapital
1 round
Armistice Capital
1 round
Marshall Wace
1 round
Novo Holdings A/S
1 round
Pivotal Life Sciences
1 round
Logos Capital
1 round
The Red Hook Fund LP
1 round
Novo Seeds
1 round
Kurma Partners
1 round
Avoro Ventures
1 round
RA Capital Management
1 round
Idinvest
1 round
Soleus Capital
1 round
EIR Ventures
1 round
Serrado Capital
1 round
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
China's leading blood products manufacturer
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/io-biotech"><img src="https://indexed.vc/api/badge/company/io-biotech" alt="IO Biotech on Indexed.vc" width="260" height="76" /></a>